Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

How Will The Open-Angle Glaucoma (OAG) Market Valuation Change Between Now And 2029?

The market for open-angle glaucoma (oag) has significantly expanded in the past few years. The market which is valued at $6.13 billion in 2024 is projected to escalate to $6.53 billion in 2025, given a Compound Annual Growth Rate (CAGR) of 6.5%. Several factors contribute to this historic growth, including the rise in glaucoma cases among the elderly, increased awareness of early eye disease detection, expansion in healthcare spending, government efforts towards eye care schemes, and a global increase in ophthalmology practices.

The open-angle glaucoma (oag) market is anticipated to witness considerable growth in the approaching years, reaching $8.36 billion by 2029 with a compound annual growth rate (CAGR) of 6.4%. Factors contributing to this optimistic forecast include intensified demand for hybrid therapies, a concentrated shift towards personalized healthcare, enhanced reimbursement strategies for glaucoma procedures, increasing instances of lifestyle-related ocular disorders and a growing preference for non-abrasive diagnostic techniques. Other projected trends include widespread adoption of artificial intelligence in glaucoma diagnosis, a move towards outpatient surgical procedures for glaucoma, increased utilization of long-lasting glaucoma implants, the integration of wearable tech for intraocular pressure monitoring, and a deepening commitment to sustainable practices in the fabrication of medical devices.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20911&type=smp

What Growth-Enabling Forces Are Impacting The Open-Angle Glaucoma (OAG) Market?

Increasing cognizance of eye conditions is anticipated to fuel the advancement of the open-angle glaucoma (OAG) market. Eye conditions include medical issues that affect the structure, function, or sight of the eyes, extending from minor problems like dry eye to grave diseases such as glaucoma and macular degeneration. The rising incidence of these conditions can be attributed to an aging population, extended screen time, a surge in diabetes cases, environmental pollution, and lifestyle patterns detrimental to eye health. Open-angle glaucoma (OAG), a predominant cause of blindness, especially in the elderly, signifies the pressing need for regular eye check-ups, timely detection, and proactive intervention to prevent irreversible vision loss. For example, in October 2023, the Royal National Institute of Blind People (RNIB), a sight loss charity in the UK, stated that eye care outpatient appointments in the UK surpassed eight million in 2021/22, making it the most sought-after specialty. Furthermore, the number of people suffering from sight loss, currently exceeding two million, is estimated to double to over four million by 2050. Hence, the escalating awareness of eye diseases is fostering growth in the open-angle glaucoma (OAG) market.

What Are The Main Segment Classifications In The Open-Angle Glaucoma (OAG) Market?

The open-angle glaucoma (oag)market covered in this report is segmented –

1) By Disease Type: Open Angle Glaucoma; Angle Closure Glaucoma; Other Disease Type

2) By Drug Class: Prostaglandin Analog; Beta Blockers; Adrenergic Agonist; Carbonic Anhydrase Inhibitors; Others Drug Class

3) By End User: Hospitals; Homecare; Specialty Clinics; Other End Users

4) By Distribution Channel: Hospital Pharmacy; Online Pharmacy; Retail Pharmacy

Subsegments:

1) By Open Angle Glaucoma (OAG): Primary Open-Angle Glaucoma (POAG); Secondary Open-Angle Glaucoma

2) By Angle Closure Glaucoma: Acute Angle-Closure Glaucoma; Chronic Angle-Closure Glaucoma

3) By Other Disease Type: Normal-Tension Glaucoma; Congenital Glaucoma; Secondary Glaucoma

How Are Market Trends Influencing Competition In The Open-Angle Glaucoma (OAG) Market?

In the open-angle glaucoma (OAG) market, leading corporations are focusing on the creation of groundbreaking methods, such as minimally invasive glaucoma devices (MIGDs), to offer superior, less invasive options for managing primary open-angle glaucoma, thereby minimizing dependence on traditional treatments. Minimally invasive glaucoma devices (MIGDs) encompass a variety of surgical techniques and implants designed to decrease intraocular pressure in glaucoma patients with minimal invasion and disruption of the eye tissues. For example, in December 2023, iSTAR Medical, a medtech firm from Belgium, introduced MINIject in the Netherlands. This breakthrough treatment for primary open-angle glaucoma uses a specially porous STAR material to improve fluid drainage and reduce intraocular pressure. By lessening the reliance on classic therapies, MINIject ushers in a new era in glaucoma treatment, offering a safer and more efficient method to manage this major cause of irreversible blindness.

Which Firms Are Driving Innovation Within The Open-Angle Glaucoma (OAG) Market?

Major companies operating in the open-angle glaucoma (OAG) market are Pfizer Inc., Merck & Co. Inc., AbbVie Inc, Novartis AG, Amgen Inc., Teva Pharmaceutical Industries Ltd., Boston Scientific, Alcon Inc., Bausch Health Companies Inc., Hoya Corporation, Sun Pharmaceutical Industries Ltd., Santen Pharmaceuticals, Mallinckrodt Pharmaceuticals, Théa Pharma, Glaukos Corporation, Quantel Medical, EyePoint Pharmaceuticals Inc., iSTAR Medical, Nicox Ophthalmics, Visus Therapeutics, Peregrine Eye Laser and Institute, Inotek Pharmaceuticals

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/open-angle-glaucoma-oag-global-market-report

What Are The Emerging Regional Trends Driving The Open-Angle Glaucoma (OAG) Market?

North America was the largest region in the open-angle glaucoma (OAG) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the open-angle glaucoma (OAG) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=20911&type=smp

Browse Through More Reports Similar to the Global Open-Angle Glaucoma (OAG) Market 2025, By The Business Research Company

Antiglaucoma Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/antiglaucoma-drugs-global-market-report

Glaucoma Surgery Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/glaucoma-surgery-devices-global-market-report

Myopia And Presbyopia Treatment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/myopia-and-presbyopia-treatment-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model